To our knowledge, this study is the largest to date on the direct determination of BV from PV and RCV in children and adolescents at various pubertal stages. Our pilot study in 31 patients aged 2 ...

The drug candidate is a bombesin analogue radioconjugated radiolabelled with 177Lu. It is based on molecular nuclear therapy that combines two approaches such as tumor targeting and radiation therapy.